New Delhi , Jan 3 : The growth trajectory for Indian pharmaceutical industry is likely to be moderate, according to credit rating agency ICRA. ... generic adoption reaching saturation levels, and regulatory overhang along with base effect catching up; the Indian pharma sector is likely to curtail aggregate ...
Read more: Indian pharma growth likely to be moderate: ICRA